
Is exercise the elixir of youth? It may lower risk of early death by up to 40%, new study finds
Follow
Doing exercises that increase your heart and breathing rate on a regular basis may reduce your risk of an early death across all causes by up to 40%, according to a new meta-analysis of 85 studies that looked at 7 million people worldwide.
'Physical activity may be even more important for long-term health than we previously thought,' study coauthor Gregore Mielke, a senior lecturer at the School of Public Health at the University of Queensland in Brisbane, Australia, said in an email.
Age didn't seem to matter — people who started exercising at older ages could also increase their longevity, said Ruyi Yu, a public health doctoral student at the University of Brisbane. In fact, the positive impact of increasing physical activity was often stronger in older adults, providing up to a '10% to 15% further reduction in risk' because they are more likely to be facing multiple health problems, she said.
'This highlights that it is never too late to start being physically active, and starting at any point in adulthood can still lead to a longer, healthier life,' Mielke said.
The findings are not surprising because physical activity is 'magic,' said Dr. Andrew Freeman, director of cardiovascular prevention and wellness at National Jewish Health in Denver, who was not involved in the study.
'Exercise truly does lower risk in a way you can't get with medications. It's amazing,' Freeman said. 'I tell my patients that physical activity is truly the elixir of youth.'
The study, published Thursday in the British Journal of Sports Medicine, is the 'most comprehensive analyses ever conducted' on physical activity from early adulthood onward, Mielke said.
'What makes this study different is that it reviewed research that tracked physical activity at multiple points over time,' he said. 'This allowed us to examine long-term patterns — such as staying active, becoming active later, or stopping activity — and how these patterns affect the risk of death.'
While exercise guidelines may differ by country, the meta-analysis applied the World Health Organization's recommendations: at least 150 to 300 minutes of moderate-intensity aerobic physical activity or 75 to 150 minutes of vigorous-intensity aerobic physical activity (or a combination) throughout the week. Vigorous-intensity exercise such as jogging or race walking really amps up your heart rate — you're likely to start to sweat after only a few minutes, according to the Mayo Clinic.
Regular aerobic exercise was most beneficial for heart disease, which is the No. 1 killer in the world. Compared with people who did little to no physical activity, those who exercised the most were about 40% less likely to die from cardiovascular disease, the study found. The risk of cancer dropped by 25%.
The largest gains in lifespan occurred when people exercised moderately at least 300 minutes a week, Yu said: 'Doing more than that didn't seem to provide much extra benefit for longevity.'
However, even couch potatoes who began to exercise consistently saw a benefit — a 22% drop in the risk of early death, the study found.
People who engaged in more leisure-time physical activity saw a 27% drop in risk as well, the study found.
Unfortunately, people who stopped exercising appeared to lose longevity momentum — they had a risk of early death similar to those who have always been inactive.
'This result is interesting as this raises an important question: do the benefits of past physical activity last if people stop being active?' Yu said. 'More research is definitely needed for this.'
While meeting official exercise guidelines is ideal, it's not the only path to better health, Mielke said.
'Even people who didn't meet the recommended levels — but maintained some level of activity — still had a lower risk of early death compared to those who remained inactive,' he said. 'We encourage people to move in whatever way works for them. What matters most is keeping your body moving and finding ways to enjoy being active.'
It's important to start slowly if you're new to exercise — and only after checking with your doctor first — but the goal is to build up to a brisk walk for at least 30 minutes a day, Freeman said.
'If you go with a friend or your spouse or partner, whoever it is, they should be able to talk to you and you should be unable to talk back because you're working so hard,' Freeman said. 'It's good for your relationship and for your body.'
You can also add some resistance to take your workout to the next level, he said.
'When I tell people to go walking or biking or swimming or jogging, I usually recommend that they do resistance concurrently,' Freeman said.
'Carry some weights with them or put on a weighted backpack, put resistance on the bike or bike uphill, and put fins on their hands when they swim so that there's resistance in the water. Do whatever they need to try to combine the cardio with strength training.'
Sign up for CNN's Fitness, But Better newsletter series. Our seven-part guide will help you ease into a healthy routine, backed by experts.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
SMSbiotech Initiates Groundbreaking Phase 1 Human Clinical Trial for COPD
MELBOURNE, Australia, August 21, 2025--(BUSINESS WIRE)--SMSbiotech, a San Diego–based leader in regenerative medicine, today announced the initiation of its first-in-human Phase 1 clinical trial for Chronic Obstructive Pulmonary Disease (COPD). This milestone marks the transition of years of dedicated research into clinical development, with the goal of delivering a transformative therapy for millions living with this debilitating lung condition. On July 11, 2025, at Veritus Research in Melbourne, Australia, the first dose of SMSbiotech's novel therapeutic candidate was administered to the inaugural patient. The Phase 1 study, titled "A study to investigate small mobile stem cells (SMS cells) in participants aged 39 to 69 years with chronic obstructive pulmonary disease," will enroll 18 COPD patients. The trial is designed to evaluate the safety and preliminary efficacy of SMSbiotech's Small Mobile Stem (SMS) cells—a unique, healthy, adult blood-derived cell population discovered and named by SMSbiotech. Unlike traditional treatments, SMS cells are designed to regenerate damaged lung tissue. The off-the-shelf, non-invasive therapy is administered directly to the lungs through a nebulizer. Preclinical studies demonstrated significant restoration of lung function in as little as 10 days. The study duration is expected to be 15 months. "The initiation of our Phase 1 trial for COPD is a profound moment for SMSbiotech and, more importantly, for the millions of patients yearning for better treatment options," said Dr. Abdulkader Rahmo, President of SMSbiotech. "We are also encouraged to report that the first two sentinel patients have been dosed, initial safety data has been received, and the trial can now move forward—an important validation step as we continue this study. We are immensely optimistic about the potential of our Small Mobile Stem cell therapy to not only manage COPD symptoms but to fundamentally alter the disease's progression and potentially reverse its devastating effects. We believe this represents a new dawn for respiratory medicine, offering the promise of a future where patients can breathe easier and live fuller lives." The trial received regulatory approval from the Therapeutic Goods Administration (TGA), Australia's regulatory authority equivalent to the U.S. Food and Drug Administration (FDA). SMSbiotech has filed 16 patents and received 7 granted patents for its technology. Pending sufficient safety data from this trial, the company plans to evaluate compassionate use applications. Encouraged by promising preclinical data, SMSbiotech is also investigating applications in orthopedics and other therapeutic areas. For more information about this clinical trial, please visit the Australian New Zealand Clinical Trials Registry at: Inquiries about study participation:Veritus ResearchPhone: +61 03 8736 1750Email: info@ About SMSbiotech SMSbiotech is a regenerative medicine company dedicated to advancing breakthrough therapies that restore tissue function and transform patient care. Leveraging its proprietary Small Mobile Stem (SMS) cell technology, SMSbiotech is focused on developing novel treatments for COPD and other debilitating diseases. View source version on Contacts Dr. Abdulkader Rahmoinfo@ 760-290-3406 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Entrepreneur
an hour ago
- Entrepreneur
This Trillion-Dollar Industry Is Where You Need to Look For Your Next Investment — Here's Why
The next trillion-dollar industry won't be social media, crypto or even AI. It will be longevity — the business of extending not just how we live, but how well we live. And the leaders who understand this now will own the future. Opinions expressed by Entrepreneur contributors are their own. Here's the uncomfortable truth: Most founders are still chasing yesterday's markets. They're building tools for productivity, or consumer apps that feel safe and familiar. Meanwhile, a new generation of companies is tackling the most universal customer need on earth — more years of energy, clarity and performance. This isn't wellness 2.0. This is the redefinition of healthcare, insurance, consumer products and even food. By 2030, the longevity economy will be worth an estimated $27 trillion globally. For business leaders, this represents a once-in-a-generation category: It touches everyone, enables recurring revenues and rewards those who build early. The real question is simple: Will you profit from it — or watch from the sidelines? Related: Why Personal Health and Wellness Are Key to Business Longevity Why longevity is the next Gold Rush For decades, healthcare has focused on treating disease. Wellness became a $5 trillion global industry filled with supplements, wearables and green juices. But now, the shift is toward healthspan — the years we spend in peak physical and mental condition. The customer demand is obvious: Aging populations: By 2034, the U.S. will have more people over 65 than 18. Globally, one in six people will be over 60 by 2030. That's not just demographics — that's a new consumer majority. By 2034, the U.S. will have more people over 65 than 18. Globally, one in six people will be over 60 by 2030. That's not just demographics — that's a new consumer majority. Rising costs: Chronic diseases and mental health conditions already account for 90% of U.S. healthcare spending. Businesses and insurers are desperate for solutions that prevent rather than patch. Chronic diseases and mental health conditions already account for 90% of U.S. healthcare spending. Businesses and insurers are desperate for solutions that prevent rather than patch. Spending power: The 50+ population already controls more than half of global consumer spending, yet most innovation still chases Gen Z. That's a blind spot waiting to be exploited. The 50+ population already controls more than half of global consumer spending, yet most innovation still chases Gen Z. That's a blind spot waiting to be exploited. Cultural momentum: From CEOs like Bryan Johnson spending millions on "biological age reversal" to mainstream adoption of WHOOP and Oura, longevity has gone from fringe to aspirational. Here's the point: Longevity is no longer about lab coats and science journals. It's becoming a consumer status symbol, a corporate necessity and a national policy issue all at once. That convergence creates rocket fuel for entrepreneurs bold enough to enter. Who's leading the charge Look at where the smartest money is already flowing: Altos Labs, backed by Jeff Bezos, is pursuing cellular reprogramming to reverse ageing itself. Thorne HealthTech is scaling biological age testing and personalized supplementation. Deep-tech startups are building senolytics (compounds that clear damaged cells), NAD+ boosters and precision nutrition platforms. Consumer brands are reframing skincare, fitness and even food around "cellular longevity." And it's not just startups. Apple and Amazon are both quietly moving into health monitoring and prevention — because they know the next trillion-dollar market won't be social feeds, it will be life itself. These aren't small plays. In 2024, longevity startups attracted $8.5 billion in funding — a 220% year-over-year increase. And yet, compared to fintech or AI, this category is still underfunded. That means the window is wide open. Related: How Entrepreneurs Can Achieve Longevity Where entrepreneurs can enter You don't need to be a biotech scientist to build here. In fact, some of the biggest near-term opportunities are business-model plays, not lab breakthroughs: Data + AI platforms: Democratize access to advanced diagnostics, biomarket testing or personalized health programs. Think of it as " for your biology." Democratize access to advanced diagnostics, biomarket testing or personalized health programs. Think of it as " for your biology." Longevity as a service: Subscription models for supplements, recovery protocols or wearables that create sticky, recurring revenue. Subscription models for supplements, recovery protocols or wearables that create sticky, recurring revenue. Talent and corporate healthspan: Companies will pay for healthier, sharper employees. Expect corporate packages for executive resilience, employee energy optimisation and "longevity perks." Companies will pay for healthier, sharper employees. Expect corporate packages for executive resilience, employee energy optimisation and "longevity perks." Consumer rebrands: Skincare, nutrition and fitness companies are already pivoting around the language of healthspan to differentiate. I've already invested in this space myself: Under my brand Rejna , I'm launching a skincare collection called Rejuvenate, built around the concept of "skinspan" — positioning skin health as a core pillar of longevity, not just cosmetics. It's a live example of how consumer brands can reframe their value proposition to align with the longevity revolution. Skincare, nutrition and fitness companies are already pivoting around the language of healthspan to differentiate. I've already invested in this space myself: Under my brand , I'm launching a skincare collection called Rejuvenate, built around the concept of "skinspan" — positioning skin health as a core pillar of longevity, not just cosmetics. It's a live example of how consumer brands can reframe their value proposition to align with the longevity revolution. Longevity communities: Hybrid digital + physical hubs offering programs, recovery lounges and memberships designed for the new aspirational class: the longevity customer. Translation for business leaders: You don't need a lab. You need vision, distribution and the courage to build for where the market is going, not where it's been. How business leaders can act now Educate yourself and your team. Follow longevity leaders (David Sinclair, Peter Diamandis and Laura Deming to name a few). Subscribe to longevity reports. Send your team to a longevity summit. Identity synergies with your business. Whether you're in food, beauty, insurance, HR or data, there's a longevity angle. If you're not thinking about it, your competitors will. Start small, scale fast. Launch a pilot offering: corporate wellness with a longevity spin, a subscription recovery service or a data product built on wearable integration. Test, learn and scale. Position for partnerships. Big pharma, insurers and consumer brands will need agile partners. If you're early, you'll be the acquisition target, not the disrupted. Signal the story. Investors and employees back vision. Frame your longevity play as part of a bigger comeback or market-defining narrative. The story matters as much as the science. Related: Why Top Entrepreneurs Are Swapping Beach Vacations for Longevity Retreats The bigger picture Longevity isn't about living forever. It's about compressing the years of illness, fatigue and decline — and extending the years of vitality, clarity and purpose. The smartest entrepreneurs understand this isn't just science, it's strategy. It's the chance to build the companies that will define the next decade of human health — and make fortunes doing it. The next trillion-dollar industry won't just help us live longer. It will help us live better. The only question is: Are you building for it now, or waiting until it's too late?


Fox News
2 hours ago
- Fox News
Woman goes blind after drinking tainted cocktail, plus red meat can help your mood
'SHOT CAN KILL YOU': Travelers have been warned to avoid certain drinks abroad because of the potentially fatal effects. WIND OF CHANGE: Hurricane Erin is bringing 100 mph winds and dangerous rip currents to coastal towns, prompting beach closures. HAPPY MEALS: A new study reveals that those who consume lean red meat as part of a healthy diet have lower rates of depression and other mental health conditions. BIG SAVINGS – From high-powered binoculars to essential home office gear, Amazon has discounts on a variety of products. Continue reading… CALLING ALL CROSSWORD PUZZLE LOVERS! – Play our Fox News daily crossword puzzle for free here! And not just one — check out the multiple offerings. See the puzzles... Fox News FirstFox News Opinion